- Home
- BLDEW vs LOT Comparison
BLDEW vs LOT Comparison
Compare BLDEW & LOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDEW
- LOT
- Stock Information
- Founded
- BLDEW 2014
- LOT 1948
- Country
- BLDEW United States
- LOT China
- Employees
- BLDEW 281
- LOT N/A
- Industry
- BLDEW Transportation Services
- LOT
- Sector
- BLDEW Consumer Discretionary
- LOT
- Exchange
- BLDEW Nasdaq
- LOT NYSE
- Market Cap
- BLDEW N/A
- LOT N/A
- IPO Year
- BLDEW N/A
- LOT N/A
- Fundamental
- Price
- BLDEW $0.23
- LOT $1.80
- Analyst Decision
- BLDEW
- LOT
- Analyst Count
- BLDEW 0
- LOT 0
- Target Price
- BLDEW N/A
- LOT N/A
- AVG Volume (30 Days)
- BLDEW 51.0K
- LOT 323.7K
- Earning Date
- BLDEW 03-13-2025
- LOT 04-07-2025
- Dividend Yield
- BLDEW N/A
- LOT N/A
- EPS Growth
- BLDEW N/A
- LOT N/A
- EPS
- BLDEW N/A
- LOT N/A
- Revenue
- BLDEW $241,814,000.00
- LOT $1,013,890,000.00
- Revenue This Year
- BLDEW N/A
- LOT $41.67
- Revenue Next Year
- BLDEW N/A
- LOT $65.29
- P/E Ratio
- BLDEW N/A
- LOT N/A
- Revenue Growth
- BLDEW 12.04
- LOT 213.08
- 52 Week Low
- BLDEW $0.30
- LOT $1.42
- 52 Week High
- BLDEW $0.36
- LOT $13.85
- Technical
- Relative Strength Index (RSI)
- BLDEW N/A
- LOT 44.59
- Support Level
- BLDEW N/A
- LOT $1.42
- Resistance Level
- BLDEW N/A
- LOT $2.42
- Average True Range (ATR)
- BLDEW 0.00
- LOT 0.20
- MACD
- BLDEW 0.00
- LOT 0.08
- Stochastic Oscillator
- BLDEW 0.00
- LOT 38.00
About BLDEW Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.